Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 28615 [2015-12056]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 96 / Tuesday, May 19, 2015 / Notices
1. David L. Johnson and Sandra L.
Castetter, both of Kansas City, Missouri;
each individually to acquire over 10
percent; and David L. Johnson and
Sandra L. Castetter, together with Park
GP, LLC, North Kansas City, Missouri,
acting in concert to acquire up to 24.99
percent of the voting shares CCSB
Financial Corp., parent of Clay County
Savings Bank, both of Liberty, Missouri.
Board of Governors of the Federal Reserve
System, May 13, 2015.
Michael J. Lewandowski,
Assistant Secretary of the Board.
[FR Doc. 2015–12034 Filed 5–18–15; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Building Local Community
Health Leadership for Action on
Preventing Chronic Disease, SIP 15–006,
initial review.
SUMMARY: This document corrects a
notice that was published in the Federal
Register on May 5, 2015, Volume 80,
Number 86, Page 25692. The time and
date should have read as follows:
11:00 a.m.–6:00 p.m.,
May 28, 2015 (Closed).
TIME AND DATE:
FOR FURTHER INFORMATION CONTACT:
tkelley on DSK3SPTVN1PROD with NOTICES
Brenda Colley Gilbert, Ph.D., M.S.P.H.,
Director, Extramural Research Program
Operations and Services, CDC, 4770
Buford Highway NE., Mailstop F–80,
Atlanta, Georgia 30341, Telephone:
(770) 488–6295, BJC4@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA) PS15–1505, Enhancing HIV
Prevention Communication and
Mobilization Efforts through Strategic
Partnerships.
Time and Date: 10:00 a.m.–1:00 p.m., EDT,
Panels 1–5; June 9, 2015 (CLOSED).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Enhancing HIV Prevention
Communication and Mobilization Efforts
through Strategic Partnerships’’ FOA PS15–
1505.
Contact Person for more Information: Lisa
R. Williams, Public Health Analyst, CDC,
1600 Clifton Road, NE., Mailstop E07,
Atlanta, Georgia 30333, Telephone: (404)
639–1877.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–12056 Filed 5–18–15; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on the proposed information
collection entitled CDC Burden of
Canine Brucellosis Information
Collection. This information collection
will help to estimate canine brucellosis
disease burden in dogs, which will aid
in the determination of the public
health importance of human B. canis
infections, and the potential for
zoonotic transmission.
DATES: Written comments must be
received on or before July 20, 2015.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2015–
0037 by any of the following methods:
• Federal eRulemaking Portal:
Regulation.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
SUMMARY:
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
BILLING CODE 4163–18–P
Jkt 235001
Proposed Data Collection Submitted
for Public Comment and
Recommendations
FOR FURTHER INFORMATION CONTACT:
[FR Doc. 2015–12054 Filed 5–18–15; 8:45 am]
16:53 May 18, 2015
[60Day–15–15AIS; Docket No. CDC–2015–
0037]
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to
the address listed above.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
VerDate Sep<11>2014
28615
Frm 00037
Fmt 4703
Sfmt 4703
E:\FR\FM\19MYN1.SGM
19MYN1
]]>Agencies
[Federal Register Volume 80, Number 96 (Tuesday, May 19, 2015)]
[Notices]
[Page 28615]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-12056]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting for the initial review of
applications in response to Funding Opportunity Announcement (FOA)
PS15-1505, Enhancing HIV Prevention Communication and Mobilization
Efforts through Strategic Partnerships.
Time and Date: 10:00 a.m.-1:00 p.m., EDT, Panels 1-5; June 9,
2015 (CLOSED).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Enhancing HIV Prevention Communication and
Mobilization Efforts through Strategic Partnerships'' FOA PS15-1505.
Contact Person for more Information: Lisa R. Williams, Public
Health Analyst, CDC, 1600 Clifton Road, NE., Mailstop E07, Atlanta,
Georgia 30333, Telephone: (404) 639-1877.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2015-12056 Filed 5-18-15; 8:45 am]
BILLING CODE 4163-18-P
